A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA
Clinical trial NCT04291937 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04291937
- Sponsor
- Jazz Pharmaceuticals
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.